Tumor Immunology and Immune Therapy of Cancer

Third-cycle level | 1.5 credits (HEC) | Course code: K7F3110
HT 2024
Study period: 2024-11-11 - 2024-11-15
LANGUAGE OF INSTRUCTION: The course is given in English
Application period: 2024-04-15 - 2024-08-10
+
HT 2025
Study period: 2025-11-10 - 2025-11-14
LANGUAGE OF INSTRUCTION: The course is given in English
Application period: 2025-04-15 - 2025-05-06
+

Course description

This course covers basic and applied immunology and a current review of experimental research and clinical application of tumor immunology. Both pre-clinical and clinical aspects of cancer vaccination, adoptive cell therapy, and antibody therapy will be discussed. Development of novel therapies through modification of immune cell subsets will be presented. Features of the tumor microenvironment, cancer-associated inflammation, immune surveillance and escape, and immunosuppression will also be discussed.

Lecturers may also share their own research activities during the presentations. One day is dedicated to lectures by invited international experts in the field.

Prerequisites and Selection

Prerequisite courses, or equivalent

No prerequisite courses, or equivalent, demanded for this course. 

Selection

Selection will be based on:  
1) the relevance of the course syllabus for the applicant’s individual study plan/research (according to written motivation). 
2) start date of doctoral studies (priority given to earlier start date). 

 

Course director

Stina Wickström and Andreas Lundqvist

Department of Oncology-Pathology

Course syllabus

K7F3110

Department

Department of Oncology-Pathology

Doctoral programme

Tumour Biology and Oncology (FoTO)

Type of course

**Other course

Keywords

Immunology, Cancer, immunologi

CONTACTStina Wickström

stina.wickstrom@ki.se